
About Altogen Labs
Altogen Labs is a Healthcare company based in Austin (United States) founded in 2008 by Dmitriy Ovcharenko. It offers xenograft models, toxicology testing, and stable cell line development for drug research. It operates on a B2B model. Its chief executive, as recorded, is Dmitriy Ovcharenko. Its website altogenlabs.com draws about 14 thousand monthly visits. Altogen Labs offers products and services including Xenograft Models, Stable Cell Lines, In Vivo siRNA Delivery, and Toxicology Testing. Its focus areas include Biotechnology, Preclinical Research, Xenograft Models and Toxicology Testing. Similar companies include Dicerna Pharmaceuticals, Rejuvenate Bio and Orna; 3 of its 3 listed similar companies have raised funding.
Company details
Altogen Labs, based in Austin, Texas, is a GLP-compliant laboratory specializing in preclinical research services. They provide xenograft animal models, pharmacology testing, and in vivo toxicology studies for pharmaceutical and academic clients. Services include stable cell line generation, RNAi delivery, and assay development to support drug efficacy and safety evaluations. The company conducts experiments using immunocompromised mice and offers detailed data reporting, focusing on cancer research and biotechnology applications.
- Headquarters Austin, United States
- Founders Dmitriy Ovcharenko
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website altogenlabs.com
- Social LinkedIn X Facebook YouTube
Products & Services of Altogen Labs
Altogen Labs offers a comprehensive portfolio of products and services, including Xenograft Models, Stable Cell Lines, In Vivo siRNA Delivery, and Toxicology Testing.
Provides animal models for cancer research and drug testing.
Develops cell lines for gene expression and drug screening studies.
Offers targeted RNA interference for therapeutic research.
Conducts toxicity assessments for drug development.
Apps and channels of Altogen Labs
its YouTube channel Altogen Labs has 1.75K subscribers and 30 videos.
Videos from Altogen Labs
The most watched videos on Altogen Labs's YouTube channel, Altogen Labs (1.75K subscribers). Click a video to play it here.
More on Altogen Labs.
People of Altogen Labs
1 people are tracked at Altogen Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dmitriy Ovcharenko | Founder, CEO | Leadership |
Complete people profiles for Altogen Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Altogen Labs
Altogen Labs has 3 listed similar companies in our database, 3 of them funded. They include Dicerna Pharmaceuticals, Rejuvenate Bio and Orna.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dicerna.com | 2007 | Lexington, United States | $106.45M | 337 | Drugs are developed using RNA interference technology platform. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| ornatx.com | 2020 | Cambridge, United States | $201M | 113 | Technologies for producing circular RNA therapeutics are developed. |
Detailed similar companies of Altogen Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Altogen Labs
The website of Altogen Labs (altogenlabs.com) receives about 14K visits a month.
- Monthly visits14K
▼ 2.1% vs previous month
Websites whose visitors overlap most with Altogen Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biocytogen.com | 100% | 23.6K | #1,249,047 | View details | |
| reactionbiology.com | 94% | 15.6K | #1,617,891 | View details | |
| cofactorgenomics.com | 83% | 4.2K | #4,572,217 | View details | |
| cellecta.com | 72% | 16.5K | #1,583,800 | View details | |
| taconic.com | 65% | 49.8K | #707,498 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Altogen Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Altogen Labs (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altogen Labs
Complete news archive for Altogen Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altogen Labs
Altogen Labs was founded in 2008.
Altogen Labs is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Dmitriy Ovcharenko is the CEO of Altogen Labs, as recorded in our data. They have also founded this company.
Altogen Labs, based in Austin, Texas, is a GLP-compliant laboratory specializing in preclinical research services. They provide xenograft animal models, pharmacology testing, and in vivo toxicology studies for pharmaceutical and academic clients. Services include stable cell line generation, RNAi delivery, and assay development to support drug efficacy and safety evaluations. The company conducts experiments using immunocompromised mice and offers detailed data reporting, focusing on cancer research and biotechnology applications.
Altogen Labs's top competitors include Dicerna Pharmaceuticals, Orna and Rejuvenate Bio.
Altogen Labs offers Xenograft Models, Stable Cell Lines, In Vivo siRNA Delivery, and Toxicology Testing.
